FindTrial
Sign In

Gum reconstruction by using injectable hyaluronic acid

Evaluation of efficacy of injectable hyaluronic acid in reconstruction of interdental papilla - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085597
Enrollment
15
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hyaluronic Acid: Sodium Hyaluronate E.P 20mg/2ml Excipients: Sodium Chloride, monobasic sodium phosphate dihydrate, Dibasic sodium phosphate dodecahydrate, Water for injections q.s to 2

Sponsors

Parveen Dahiya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non-smoking patient. Had at least one site with interdental papilla recession in the anterior region of the maxillary and mandibular jaws. No active periodontal diseases and good oral hygiene.

Exclusion criteria

Exclusion criteria: If patient have spacing or crowding between the teeth to be treated, abnormal tooth shape, systemic diseases such as diabetes mellitus, hypertension or conditions that alter the outcome of periodontal therapy. Pregnant and lactating women and tobacco users excluded.

Design outcomes

Primary

MeasureTime frame
inter-papillary regenerationTimepoint: 3 months—

Secondary

MeasureTime frame
subject perspective towards esthetic zoneTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Parveen Dahiya

Department of Periodontics and Implantology Himachal Institute of Dental Sciences , Paonta Sahib

parveen_132@yahoo.com9857373300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026